1. Home
  2. PD vs RCKT Comparison

PD vs RCKT Comparison

Compare PD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$6.18

Market Cap

636.9M

Sector

Technology

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.74

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
RCKT
Founded
2009
1999
Country
United States
United States
Employees
N/A
202
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.9M
534.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PD
RCKT
Price
$6.18
$3.74
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$12.63
$29.65
AVG Volume (30 Days)
3.1M
3.9M
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
1.87
N/A
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
N/A
Revenue Next Year
$1.65
$51.17
P/E Ratio
$3.21
N/A
Revenue Growth
5.36
N/A
52 Week Low
$5.92
$2.19
52 Week High
$18.51
$8.26

Technical Indicators

Market Signals
Indicator
PD
RCKT
Relative Strength Index (RSI) 30.75 40.19
Support Level $6.17 $2.99
Resistance Level $16.47 $4.08
Average True Range (ATR) 0.42 0.37
MACD -0.03 -0.13
Stochastic Oscillator 14.29 9.00

Price Performance

Historical Comparison
PD
RCKT

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: